|
A.V. Kuzmenko, V.V. Kuzmenko, T.A. Gyaurgiev
Postcovid complications in urology. prevention
|
№3 / 2022
|
|
Yu.Yu. Vinnik, A.V. Kuzmenko, T.A. Gyaurgiev
Treatment of the chronic prostatitis:
current state of the problem
|
№4 / 2021
|
|
A.V. Kuzmenko, Yu.Yu. Vinnik, V.V. Kuzmenko, T.A. Gyaurgiev
The use of bioregulatory peptides in the treatment of men with benign prostatic hyperplasia and chronic prostatitis
|
№3 / 2021
|
|
M.I. Davidov
Sexual dysfunction in patients with chronic prostatitis and its treatment
|
№1 / 2020
|
|
D.V. Ergakov, A.G. Martov, D.E. Turin
Use of cytomedins in case of prostatic involvement in chronic prostatitis according to UPOINT classification
|
№3 / 2019
|
|
B.A. Neymark, A.I. Neymark, A.V. Davydov, I.I. Klepikova, N.A. Nozdrachev, M.V. Razdorskaya
Role of Cytomedines in the Treatment of Patients with Chronic Prostatitis Associated with Impaired Spermatogenesis
|
№5 / 2015
|
|
Ju. S. Kondrat’eva, A. I. Nejmark, Ja. D. Zheltikova, E. A. Subbotin
Correction of blood cir-culation in the prostate in patients with chronic prostatitis associated with urogenital infections
|
№2 / 2015
|
|
A.I. Neimark, B.A. Neimark, A.V. Davydov, I.I. Klepikova, N.A. Nozdrachev
The use of the drug vitaprost in patients with chronic prostatitis accompanied by disorders of spermato- genesis
|
№4 / 2014
|
|
D.V. Ergakov, A.G. Martov.
Application of rectal suppositories vitaprost plus before and after transurethral resection of the prostate
|
№2 / 2013
|
Русский
